Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites.
The anticonvulsant effect of primidone was determined in gerbils, in which seizures were elicited by a blast of compressed air, over the time range of 30 min to 18 h after oral administration. ED50s remained fairly constant from 1 to 12 h after administration: 46-73 mumol/kg with the minimal value at 6 h. Of the metabolites, phenobarbital was maximally effective at 2 h after administration (ED50 35 mumol/kg), whereas phenylethylmalondiamide (PEMA) only had a weak anticonvulsant effect (ED50 1.55 mmol/kg at 2 h). By determination of primidone and its active metabolites in plasma and brain at 1, 4 and 12 h after administration of the respective ED50s, it could be shown that unchanged primidone is mostly responsible for the anticonvulsant effect of the first hours, but, at 12 h, only phenobarbital could be detected in both tissues. PEMA could not be detected in brain. From the effective brain concentrations at different times it could be calculated that primidone and phenobarbital have the same anticonvulsant potency on a molar base in the gerbil. The concentrations necessary to control seizures in this model were considerably lower than those needed to suppress convulsions in maximal seizure models in mice and rats.
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000378:metabolism; D002849:Chromatography, Gas; D005849:Gerbillinae; D010634:Phenobarbital / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D010657:Phenylethylmalonamide / Q000097:blood / Q000378:metabolism; D011324:Primidone / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy*
D011324:Primidone; D010657:Phenylethylmalonamide; D010634:Phenobarbital